| BIOA | | BioAge Labs, Inc. | Paul D. Rubin | Chief Medical Officer | Dec 09, 2025 | Option/RSU Exercise | $6.57 | 18,000 | 118,260 | 18,000 | Dec 11, 2025, 04:21 PM |
| BIOA | | BioAge Labs, Inc. | Paul D. Rubin | Chief Medical Officer | Dec 09, 2025 | Sale | $12.00 | 18,000 | 216,000 | 0 | Dec 11, 2025, 04:21 PM |
| BIOA | | BioAge Labs, Inc. | Paul D. Rubin | Chief Medical Officer | Dec 04, 2025 | Option/RSU Exercise | $4.11 | 68,897 | 283,167 | 68,897 | Dec 05, 2025, 06:20 PM |
| BIOA | | BioAge Labs, Inc. | Paul D. Rubin | Chief Medical Officer | Dec 04, 2025 | Sale | $10.19 | 68,897 | 701,909 | 0 | Dec 05, 2025, 06:20 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Mar 18, 2016 | Option/RSU Exercise | - | 12,141 | - | 350,795 | Mar 22, 2016, 09:01 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Mar 22, 2016 | Sale | $0.78 | 24,194 | 18,985 | 326,601 | Mar 22, 2016, 09:01 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Aug 14, 2015 | Disposition to Issuer | $0.83 | 10,801 | 9,003 | 138,292 | Aug 18, 2015, 08:24 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Aug 14, 2015 | Option/RSU Exercise | - | 26,748 | - | 149,093 | Aug 18, 2015, 08:24 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Jul 15, 2015 | Option/RSU Exercise | $3.04 | 5,000 | 15,200 | 127,345 | Jul 17, 2015, 06:02 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Jul 15, 2015 | Sale | $4.60 | 5,000 | 22,992 | 122,345 | Jul 17, 2015, 06:02 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Jul 10, 2015 | Option/RSU Exercise | $3.04 | 29,000 | 88,160 | 151,345 | Jul 10, 2015, 06:57 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Jul 10, 2015 | Sale | $4.55 | 29,000 | 131,985 | 122,345 | Jul 10, 2015, 06:57 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Jul 09, 2015 | Option/RSU Exercise | $3.04 | 4,400 | 13,376 | 126,745 | Jul 10, 2015, 06:57 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Jul 09, 2015 | Sale | $4.55 | 4,400 | 20,020 | 122,345 | Jul 10, 2015, 06:57 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | May 28, 2015 | Option/RSU Exercise | - | 4,666 | - | 124,133 | Jun 01, 2015, 06:24 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | May 28, 2015 | Sale | $3.60 | 1,788 | 6,437 | 122,345 | Jun 01, 2015, 06:24 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Mar 23, 2015 | Sale | $3.94 | 32,742 | 128,879 | 119,467 | Mar 23, 2015, 06:35 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Mar 18, 2015 | Disposition to Issuer | $4.01 | 20,535 | 82,356 | 163,906 | Mar 20, 2015, 07:30 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Mar 18, 2015 | Option/RSU Exercise | - | 30,346 | - | 172,744 | Mar 20, 2015, 07:30 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Dec 15, 2014 | Option/RSU Exercise | $3.04 | 1,600 | 4,864 | 73,621 | Dec 16, 2014, 01:01 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Dec 15, 2014 | Sale | $4.63 | 1,600 | 7,401 | 72,021 | Dec 16, 2014, 01:01 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Nov 20, 2014 | Option/RSU Exercise | $3.04 | 5,000 | 15,200 | 77,021 | Nov 21, 2014, 02:46 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Nov 20, 2014 | Sale | $4.55 | 5,000 | 22,750 | 72,021 | Nov 21, 2014, 02:46 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Oct 28, 2014 | Option/RSU Exercise | $3.04 | 5,000 | 15,200 | 77,021 | Oct 29, 2014, 03:11 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Oct 28, 2014 | Sale | $4.57 | 5,000 | 22,829 | 72,021 | Oct 29, 2014, 03:11 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sep 15, 2014 | Sale | $4.59 | 5,000 | 22,938 | 72,021 | Sep 16, 2014, 04:41 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sep 15, 2014 | Option/RSU Exercise | $3.04 | 5,000 | 15,200 | 77,021 | Sep 16, 2014, 04:41 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sep 04, 2014 | Sale | $4.56 | 10,000 | 45,640 | 72,021 | Sep 08, 2014, 05:17 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sep 04, 2014 | Option/RSU Exercise | $3.04 | 10,000 | 30,400 | 82,021 | Sep 08, 2014, 05:17 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Aug 14, 2014 | Option/RSU Exercise | - | 26,748 | - | 98,769 | Aug 19, 2014, 12:47 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Aug 15, 2014 | Sale | $4.31 | 10,299 | 44,341 | 88,470 | Aug 19, 2014, 12:47 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Aug 18, 2014 | Sale | $4.36 | 16,449 | 71,752 | 72,021 | Aug 19, 2014, 12:47 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Jun 16, 2014 | Sale | $4.54 | 11,580 | 52,595 | 72,021 | Jun 18, 2014, 05:14 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | May 28, 2014 | Option/RSU Exercise | - | 4,667 | - | 85,386 | May 29, 2014, 05:48 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | May 28, 2014 | Sale | $4.22 | 1,785 | 7,533 | 83,601 | May 29, 2014, 05:48 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | May 13, 2014 | Sale | $3.84 | 10,000 | 38,404 | 80,719 | May 15, 2014, 03:16 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Mar 18, 2014 | Option/RSU Exercise | $0.50 | 36,347 | 18,240 | 97,707 | Mar 20, 2014, 03:38 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Mar 18, 2014 | Sale | $6.31 | 17,649 | 111,423 | 90,719 | Mar 20, 2014, 03:38 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Feb 18, 2014 | Option/RSU Exercise | $3.04 | 6,000 | 18,240 | 9,228 | Feb 19, 2014, 04:36 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Feb 18, 2014 | Sale | $7.55 | 6,000 | 45,272 | 3,228 | Feb 19, 2014, 04:36 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Jan 21, 2014 | Option/RSU Exercise | $3.04 | 5,694 | 17,310 | 8,922 | Jan 23, 2014, 05:25 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Jan 21, 2014 | Sale | $8.27 | 6,000 | 49,608 | 3,228 | Jan 23, 2014, 05:25 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Dec 18, 2013 | Option/RSU Exercise | $3.04 | 6,000 | 18,240 | 9,534 | Dec 18, 2013, 06:54 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Dec 18, 2013 | Sale | $5.67 | 6,000 | 33,992 | 3,534 | Dec 18, 2013, 06:54 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Nov 27, 2013 | Option/RSU Exercise | $3.04 | 4,696 | 14,276 | 8,230 | Dec 02, 2013, 01:19 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Nov 27, 2013 | Sale | $4.54 | 4,696 | 21,320 | 3,534 | Dec 02, 2013, 01:19 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Nov 18, 2013 | Option/RSU Exercise | $2.36 | 1,304 | 3,077 | 4,838 | Nov 19, 2013, 03:20 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Nov 18, 2013 | Sale | $4.08 | 1,304 | 5,317 | 3,534 | Nov 19, 2013, 03:20 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Oct 18, 2013 | Sale | $4.71 | 5,254 | 24,725 | 3,534 | Nov 01, 2013, 05:33 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Oct 18, 2013 | Option/RSU Exercise | $2.36 | 746 | 1,761 | 9,534 | Oct 21, 2013, 04:54 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Oct 18, 2013 | Sale | $4.71 | 746 | 3,511 | 8,788 | Oct 21, 2013, 04:54 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sep 30, 2013 | Small Acquisition | $4.27 | 459 | 1,958 | 8,788 | Oct 02, 2013, 05:29 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sep 18, 2013 | Sale | $4.53 | 6,000 | 27,187 | 8,329 | Sep 19, 2013, 05:50 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Aug 19, 2013 | Sale | $3.74 | 6,000 | 22,419 | 14,329 | Aug 19, 2013, 06:37 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Aug 14, 2013 | Option/RSU Exercise | - | 26,748 | - | 30,849 | Aug 16, 2013, 07:49 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Aug 14, 2013 | Sale | $3.86 | 10,520 | 40,621 | 20,329 | Aug 16, 2013, 07:49 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Jul 18, 2013 | Option/RSU Exercise | $2.73 | 6,000 | 16,371 | 7,353 | Jul 19, 2013, 02:59 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Jul 18, 2013 | Sale | $4.71 | 6,000 | 28,233 | 4,101 | Jul 19, 2013, 02:59 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Jun 28, 2013 | Option/RSU Exercise | $3.45 | 567 | 1,955 | 4,101 | Jul 01, 2013, 04:24 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Jun 18, 2013 | Option/RSU Exercise | $2.36 | 3,130 | 7,387 | 9,534 | Jun 18, 2013, 07:48 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | May 28, 2013 | Option/RSU Exercise | - | 4,667 | - | 8,201 | May 29, 2013, 06:46 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | May 29, 2013 | Sale | $4.16 | 1,797 | 7,476 | 6,404 | May 29, 2013, 06:46 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | May 20, 2013 | Option/RSU Exercise | $2.36 | 785 | 1,853 | 9,534 | May 21, 2013, 07:24 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | May 20, 2013 | Sale | $4.16 | 785 | 3,266 | 8,749 | May 21, 2013, 07:24 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Mar 28, 2013 | Option/RSU Exercise | $3.32 | 1,498 | 4,967 | 14,749 | Apr 01, 2013, 04:59 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Mar 18, 2013 | Option/RSU Exercise | - | 18,205 | - | 20,241 | Mar 27, 2013, 05:31 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Mar 19, 2013 | Sale | $3.29 | 6,990 | 22,997 | 13,251 | Mar 27, 2013, 05:31 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Dec 31, 2012 | Option/RSU Exercise | $2.28 | 833 | 1,899 | 2,036 | Jan 02, 2013, 04:57 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sep 28, 2012 | Option/RSU Exercise | $3.51 | 542 | 1,900 | 1,203 | Oct 01, 2012, 06:02 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Jun 29, 2012 | Option/RSU Exercise | $2.83 | 661 | 1,871 | 661 | Jul 02, 2012, 05:52 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Jun 15, 2012 | Gift | - | 3,887 | - | 0 | Jul 02, 2012, 05:52 PM |
| XOMA | | XOMA Corp | Paul D. Rubin | VP Clinical Dev. & CMO | Mar 30, 2012 | Option/RSU Exercise | $2.63 | 1,229 | 3,234 | 3,887 | Apr 02, 2012, 04:09 PM |
| XOMA | | XOMA LTD /DE/ | Paul D. Rubin | VP Clinical Dev. & CMO | Sep 30, 2011 | Option/RSU Exercise | $1.66 | 1,022 | 1,699 | 1,022 | Oct 03, 2011, 04:52 PM |
